Nanoodor Particles Deliver Drugs to Central Nervous System via Olfactory Pathway
Advanced Science,
Год журнала:
2025,
Номер
unknown
Опубликована: Фев. 25, 2025
Central
nervous
system
(CNS)
disorders
confront
significant
challenges
in
drug
delivery
due
to
the
blood-brain
barrier
(BBB).
Inspired
by
rapid
and
precise
binding
of
odor
molecules
olfactory
receptors
(ORs),
this
research
uses
thiolated
HPMA
construct
nanoparticles
(nanoodors)
capable
delivering
drugs
CNS
via
olfacto-cerebral
pathway
overcome
obstruction.
The
nanoodor
core
is
used
encapsulate
agomelatine
(AGO),
a
CNS-targeting
antidepressant,
encapsulation
efficiency
exceeded
80%.
A
series
thiol-presenting
nanoscale
structures
with
different
surface
densities
thiol
groups
are
constructed,
effectiveness
positively
correlated
density
on
their
surface.
Notably,
nanoodors
enable
brain-targeted
delivery,
outperforming
commercially
available
oral
formulations
terms
accumulation
brain
antidepressant
effects.
study
transport
action
mechanisms
revealed
that
after
ORs,
rapidly
delivered
pathway.
Nanoodors,
first
design
deliver
mimicking
natural
smells
for
treatment
disorders,
expected
achieve
clinical
transformation,
benefiting
human
health.
Язык: Английский
Nanoparticle-Based Biomarkers for Neurological Disorders
Nanotechnology in the life sciences,
Год журнала:
2025,
Номер
unknown, С. 183 - 202
Опубликована: Янв. 1, 2025
Язык: Английский
Extracellular vesicles: new horizons in neurodegeneration
EBioMedicine,
Год журнала:
2025,
Номер
113, С. 105605 - 105605
Опубликована: Март 1, 2025
Extracellular
vesicles
(EVs)
are
lipid-enclosed
nanovesicles
secreted
by
diverse
cell
types
that
orchestrate
intercellular
communication
through
cargo
delivery.
Their
pivotal
roles
span
from
supporting
the
development
of
normal
central
nervous
system
(CNS)
to
contributing
pathogenesis
neurological
diseases.
Particularly
noteworthy
is
their
involvement
in
propagation
pathogenic
proteins,
such
as
those
involved
neurodegenerative
disorders,
and
nucleic
acids,
closely
linking
them
disease
onset
progression.
Moreover,
EVs
have
emerged
promising
diagnostic
biomarkers
for
disorders
tools
staging,
owing
ability
traverse
blood-brain
barrier
specific,
stable,
accessible
properties.
This
review
comprehensively
explores
realm
CNS-derived
found
peripheral
blood,
encompassing
detection
methods,
transport
mechanisms,
various
Furthermore,
we
evaluate
potentials
limitations
clinical
applications
highlight
prospective
research
directions
this
rapidly
evolving
field.
Язык: Английский
Extracellular vesicle therapy in neurological disorders
Journal of Biomedical Science,
Год журнала:
2024,
Номер
31(1)
Опубликована: Авг. 25, 2024
Abstract
Extracellular
vesicles
(EVs)
are
vital
for
cell-to-cell
communication,
transferring
proteins,
lipids,
and
nucleic
acids
in
various
physiological
pathological
processes.
They
play
crucial
roles
immune
modulation
tissue
regeneration
but
also
involved
pathogenic
conditions
like
inflammation
degenerative
disorders.
EVs
have
heterogeneous
populations
cargo,
with
numerous
subpopulations
currently
under
investigations.
EV
therapy
shows
promise
stimulating
repair
serving
as
a
drug
delivery
vehicle,
offering
advantages
over
cell
therapy,
such
ease
of
engineering
minimal
risk
tumorigenesis.
However,
challenges
remain,
including
inconsistent
nomenclature,
complex
characterization,
underdeveloped
large-scale
production
protocols.
This
review
highlights
the
recent
advances
significance
heterogeneity,
emphasizing
need
better
understanding
their
disease
pathologies
to
develop
tailored
therapies
clinical
applications
neurological
Graphical
abstract
Язык: Английский
Dual-stimuli responsive nanoparticles for co-delivery of small molecules to promote neural differentiation of human iPSCs
Nanoscale,
Год журнала:
2024,
Номер
unknown
Опубликована: Дек. 23, 2024
The
differentiation
of
human
induced
pluripotent
stem
cells
(hiPSCs)
into
neural
progenitor
(NPCs)
is
a
promising
approach
for
the
treatment
neurodegenerative
diseases
and
regenerative
medicine.
Язык: Английский